Cullen/Frost Bankers, Inc. Avanos Medical, Inc. Transaction History

Cullen/Frost Bankers, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.97 - $22.68 $664 - $839	37 New	37 $0
Q1 2023 May 05, 2023	BUY	$26.92 - $31.75 $242 - $285	9 New	9 $0
Q3 2020 Nov 05, 2020	SELL	$28.67 - $34.32 $120,327 - $144,041	-4,197 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$23.48 - $33.86 $98,545 - $142,110	4,197 New	4,197 $123,000
Q1 2020 May 01, 2020	SELL	$20.64 - $34.41 $1,300 - $2,167	-63 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$32.06 - $44.0 $2,019 - $2,772	63 New	63 $2,000
Q2 2019 Aug 01, 2019	SELL	$37.68 - $46.52 $1,055 - $1,302	-28 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$39.84 - $51.04 $1,115 - $1,429	28 New	28 $1,000

274

42.2M

5.4K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $751M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.